Literature DB >> 8480675

Resting energy expenditure in human immunodeficiency virus-infected patients: comparison between patients with and without secondary infections.

J C Melchior1, G Raguin, A Boulier, E Bouvet, D Rigaud, S Matheron, E Casalino, J L Vilde, F Vachon, J P Coulaud.   

Abstract

Resting energy expenditure (REE) was measured in 165 malnourished patients with human immunodeficiency virus infection and compared with that of 31 control subjects. Of these patients, 129 had no symptoms of secondary infections (NI), whereas 36 had evolving secondary infection (I) despite a body temperature < 38 degrees C. Mean REE was 11% higher in the NI group than in the control group (P < 0.05); it was 34% higher in the I group than in the control group (P < 0.001) and 21% higher than in the NI group (P < 0.01). In all cases the best predictive variable for REE was the fat-free mass (FFM) (r = 0.77, P < 0.001 in NI; r = 0.70, P < 0.001 in I; r = 0.78 in the control group. The REE-FFM ratio was 152.5 +/- 1.2 and 207 +/- 5.4 kJ.kg-1.d-1 in the NI and I groups, respectively. A high energy expenditure may be a harbinger of secondary infection in acquired immunodeficiency syndrome and may participate in accelerated weight loss.

Entities:  

Mesh:

Year:  1993        PMID: 8480675     DOI: 10.1093/ajcn/57.5.614

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  13 in total

Review 1.  Adipose Tissue in HIV Infection.

Authors:  John R Koethe
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

2.  Brief Report: Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor-Based Regimens.

Authors:  Jamison Norwood; Megan Turner; Carmen Bofill; Peter Rebeiro; Bryan Shepherd; Sally Bebawy; Todd Hulgan; Stephen Raffanti; David W Haas; Timothy R Sterling; John R Koethe
Journal:  J Acquir Immune Defic Syndr       Date:  2017-12-15       Impact factor: 3.731

3.  Nutritional aspects of HIV-associated wasting in sub-Saharan Africa.

Authors:  John R Koethe; Douglas C Heimburger
Journal:  Am J Clin Nutr       Date:  2010-02-10       Impact factor: 7.045

Review 4.  Metabolic consequences of HIV: pathogenic insights.

Authors:  Amanda L Willig; E Turner Overton
Journal:  Curr HIV/AIDS Rep       Date:  2014-03       Impact factor: 5.071

5.  Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in Tuberculosis.

Authors:  Lauren S Peetluk; Peter F Rebeiro; Marcelo Cordeiro-Santos; Afranio Kritski; Bruno B Andrade; Betina Durovni; Solange Calvacante; María B Arriaga; Megan M Turner; Marina C Figueiredo; Valeria C Rolla; Timothy R Sterling
Journal:  J Infect Dis       Date:  2020-04-07       Impact factor: 5.226

Review 6.  Energy expenditure in HIV infection.

Authors:  Lisa Kosmiski
Journal:  Am J Clin Nutr       Date:  2011-11-16       Impact factor: 7.045

7.  Effect of breastfeeding on mortality among HIV-1 infected women: a randomised trial.

Authors:  R Nduati; B A Richardson; G John; D Mbori-Ngacha; A Mwatha; J Ndinya-Achola; J Bwayo; F E Onyango; J Kreiss
Journal:  Lancet       Date:  2001-05-26       Impact factor: 79.321

Review 8.  From Wasting to Obesity: The Contribution of Nutritional Status to Immune Activation in HIV Infection.

Authors:  John R Koethe; Douglas C Heimburger; George PrayGod; Suzanne Filteau
Journal:  J Infect Dis       Date:  2016-10-01       Impact factor: 5.226

Review 9.  Macronutrient supplementation for malnourished HIV-infected adults: a review of the evidence in resource-adequate and resource-constrained settings.

Authors:  John R Koethe; Benjamin H Chi; Karen M Megazzini; Douglas C Heimburger; Jeffrey S A Stringer
Journal:  Clin Infect Dis       Date:  2009-09-01       Impact factor: 9.079

10.  Bone metabolism dysfunction mediated by the increase of proinflammatory cytokines in chronic HIV infection.

Authors:  Erika Grasiela Marques de Menezes; Alcyone Artioli Machado; Fernando Barbosa; Francisco José Albuquerque de Paula; Anderson Marliere Navarro
Journal:  J Bone Miner Metab       Date:  2016-03-29       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.